The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Completed · Phase 2 · Has a placebo group

Conditions studied: Smoking Lapse Behavior

In brief

The purpose of this study is to examine how smoking cessation medications (varenicline, bupropion) affect the ability to resist smoking and also subsequent ad-lib smoking in non-treatment seeking daily smokers.

Key facts

Study ID
NCT00580853
Run by
Yale University
People needed
62
Starts
2007-04-01
Expected to finish
2016-10-01
Last updated by the study team
2018-02-08

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.